MDxHealth (MDXH) Cash from Financing Activities (2021 - 2026)
MDxHealth (MDXH) posted Cash from Financing Activities of $16.1 million for Q1 2026, up 98.51% sequentially from $8.1 million in Q3 2025, and down 25.0% YoY from $21.5 million in Q1 2025.
MDxHealth (MDXH) Cash from Financing Activities (2021 - 2026) Analysis & Trends
MDxHealth has reported Cash from Financing Activities for 5 years, with the latest figure at $16.1 million in Q1 2026.
- Quarterly Cash from Financing Activities fell 25.0% year-over-year to $16.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $55.5 million (up 0.71% YoY) and the FY2025 annual result came in at $3.0 million, down 93.35% from the prior year.
- Cash from Financing Activities advanced to $16.1 million in Q1 2026 per MDXH's latest filing, from $8.1 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $33.6 million in Q3 2024 and troughed at -$814000.0 in Q1 2022.
- A 4-year average of $11.0 million and a median of $9.0 million in 2025 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2025 and 2026: Cash from Financing Activities plunged 75.81% in 2025, then dropped 25.0% in 2026.
- Over 4 years, Cash from Financing Activities stood at -$799000.0 in 2022, then soared by 210.64% to $884000.0 in 2024, then jumped by 818.33% to $8.1 million in 2025, then surged by 98.51% to $16.1 million in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $16.1 million, $8.1 million, and $9.8 million for Q1 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | -1.57 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 7.27 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -325.19 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -144.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -214.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 3.76 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -129.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -317.75 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -229.00 Mn |
| 10 | MDxHealth | 21.81 Mn | -21.34 Mn | 16.61 Mn | 16.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.12 Mn |
| Mar 31, 2026 | 16.12 Mn |
| Sep 30, 2025 | 8.12 Mn |
| Sep 30, 2025 | 8.12 Mn |
| Jun 30, 2025 | 9.80 Mn |
| Jun 30, 2025 | 9.80 Mn |
| Mar 31, 2025 | 21.49 Mn |
| Mar 31, 2025 | 21.49 Mn |
| Dec 31, 2024 | 884,000.00 |
| Dec 31, 2024 | 884,000.00 |
| Sep 30, 2024 | 33.55 Mn |
| Sep 30, 2024 | 33.55 Mn |
| Jun 30, 2022 | -799,000.00 |
| Jun 30, 2022 | -799,000.00 |
| Mar 31, 2022 | -814,000.00 |
| Mar 31, 2022 | -814,000.00 |
| Dec 31, 2021 | 39.67 Mn |
| Dec 31, 2021 | 39.67 Mn |
| Sep 30, 2021 | -459,000.00 |
| Sep 30, 2021 | -459,000.00 |